Literature DB >> 23455885

The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.

Jian-Ye Liu1, Yong-Hong Li, Zhi-Ling Zhang, Kai Yao, Yun-Lin Ye, Dan Xie, Hui Han, Zhou-Wei Liu, Zi-Ke Qin, Fang-Jian Zhou.   

Abstract

OBJECTIVE: To evaluate factors in penile squamous cell carcinoma predictive of pelvic lymph node metastasis and survival.
MATERIALS AND METHODS: Data were collected and analyzed retrospectively in 146 patients with squamous cell carcinoma of penis who underwent bilateral inguinal lymph node dissection in our center between January 1998 and April 2011. Variables recorded included serum squamous cell carcinoma antigen, primary tumor p53 immunoreactivity, histological grade, pathological tumor stage, lymphatic or vascular invasion, absent/unilateral or bilateral inguinal lymph node involvement, number of metastatic inguinal lymph nodes, presence of extracapsular growth and lymph node density.
RESULTS: Seventy patients had inguinal lymph node metastasis (LNM). Of these, 33 (47.1%) had pelvic LNM. Primary tumor strong p53 expression, lymphatic or vascular invasion, involvement of more than two inguinal lymph nodes and 30% or greater lymph node density were significant predictors of pelvic LNM. Primary tumor strong p53 expression (odds ratio [OR] 5.997, 95% confidence intervals [CI] 1.615-22.275), presence of extracapsular growth (OR 2.209, 95% CI 1.166-4.184), involvement of more than two inguinal lymph nodes (OR 2.494, 95% CI 1.086-5.728) and pelvic lymph node involvement (OR 18.206, 95% CI 6.807-48.696) were independent prognostic factors for overall survival.
CONCLUSIONS: Primary tumor expression of p53, lymphatic or vascular invasion, number of metastatic inguinal lymph nodes and lymph node density were all predictors of pathologic pelvic lymph node involvement. Patients with pelvic LNM had an adverse prognosis, with a 3-year overall survival rate of approximately 12.1%. Pelvic lymph node dissection should be considered in these cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455885     DOI: 10.1007/s00345-013-1024-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  25 in total

1.  Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma.

Authors:  Niels M Graafland; Hester H van Boven; Erik van Werkhoven; Luc M F Moonen; Simon Horenblas
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

Review 2.  Contemporary management of penile squamous cell carcinoma.

Authors:  Bin K Kroon; Simon Horenblas; Omgo E Nieweg
Journal:  J Surg Oncol       Date:  2005-01-01       Impact factor: 3.454

3.  Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis.

Authors:  G Pizzocaro; L Piva
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

4.  Prognostic factors in Chinese patients with penile invasive squamous cell carcinoma.

Authors:  Xiaopeng Chen; Xuesong Li; Maurice M Garcia; Kan Gong; Yi Song; Zhisong He; Liqun Zhou
Journal:  J Androl       Date:  2012-06-28

5.  Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  A L Bezerra; A Lopes; G H Santiago; K C Ribeiro; M R Latorre; L L Villa
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

Review 6.  The role of lymphadenectomy in penile cancer.

Authors:  Ricardo F Sánchez-Ortiz; Curtis A Pettaway
Journal:  Urol Oncol       Date:  2004 May-Jun       Impact factor: 3.498

7.  Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Authors:  S Horenblas; H van Tinteren; J F Delemarre; L M Moonen; V Lustig; E W van Waardenburg
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

8.  Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology.

Authors:  S Horenblas; H Van Tinteren; J F Delemarre; L M Moonen; V Lustig; R Kröger
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

9.  p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  Ademar Lopes; Artur Licio R Bezerra; Clovis Antonio Lopes Pinto; Sergio Vicente Serrano; Celso Abdon de MellO; Luisa Lina Villa
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more
  15 in total

1.  Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study.

Authors:  Dominic H Tang; Rosa Djajadiningrat; Gregory Diorio; Juan Chipollini; Zhenjun Ma; Braydon J Schaible; Mario Catanzaro; Dingwei Ye; Yao Zhu; Nicola Nicolai; Simon Horenblas; Peter A S Johnstone; Philippe E Spiess
Journal:  Urol Oncol       Date:  2017-06-27       Impact factor: 3.498

2.  Extent of pelvic lymph node dissection in penile cancer may impact survival.

Authors:  Kamran Zargar-Shoshtari; Pranav Sharma; Rosa Djajadiningrat; Mario Catanzaro; Ding-Wei Ye; Yao Zhu; Nicola Nicolai; Simon Horenblas; Philippe E Spiess
Journal:  World J Urol       Date:  2015-05-31       Impact factor: 4.226

3.  Tumor Location May Independently Predict Survival in Patients With M0 Squamous Cell Carcinoma of the Penis.

Authors:  Kai Li; Xiang Le; Jianqing Wang; Caibin Fan; Jian Sun
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 4.  [Conventional grading vs. molecular grading : Decision aids for clinical routine].

Authors:  C Kakies; D Louise Dräger; P Spiess; O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2021-06-28       Impact factor: 0.639

5.  Clinical Significance of p53 and p16(ink4a) Status in a Contemporary North American Penile Carcinoma Cohort.

Authors:  Kamran Zargar-Shoshtari; Philippe E Spiess; Anders E Berglund; Pranav Sharma; Julio M Powsang; Anna Giuliano; Anthony M Magliocco; Jasreman Dhillon
Journal:  Clin Genitourin Cancer       Date:  2015-12-23       Impact factor: 2.872

6.  The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer.

Authors:  Zhigang Yuan; Arash O Naghavi; Dominic Tang; Youngchul Kim; Kamran A Ahmed; Jasreman Dhillon; Anna R Giuliano; Philippe E Spiess; Peter A Johnstone
Journal:  World J Urol       Date:  2018-03-27       Impact factor: 4.226

7.  The importance of extranodal extension in penile cancer: a meta-analysis.

Authors:  Zhi-Ling Zhang; Chun-Ping Yu; Zhuo-Wei Liu; Liliya Velet; Yong-Hong Li; Li-Juan Jiang; Fang-Jian Zhou
Journal:  BMC Cancer       Date:  2015-10-28       Impact factor: 4.430

8.  The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.

Authors:  Julie Steinestel; Andreas Al Ghazal; Annette Arndt; Thomas J Schnoeller; Andres J Schrader; Peter Moeller; Konrad Steinestel
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

9.  Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.

Authors:  Mark W Ball; Zeyad R Schwen; Joan S Ko; Alexa Meyer; George J Netto; Arthur L Burnett; Trinity J Bivalacqua
Journal:  Investig Clin Urol       Date:  2017-01-04

Review 10.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.